Journal ArticleOPEN ACCESS

Suggested risk factor for oral lichen planus arising after mRNA COVID ‐19 vaccination

  • Zargaran M
Clinical Case Reports (2022) 10(7)
DOI: 10.1002/ccr3.6126
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).

Cite

CITATION STYLE

APA

Zargaran, M. (2022). Suggested risk factor for oral lichen planus arising after                    mRNA COVID                    ‐19 vaccination. Clinical Case Reports, 10(7). https://doi.org/10.1002/ccr3.6126

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free